Portage Biotech Announces Participation in September 2021 Investor Conferences
WESTPORT, Conn., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG) (“Portage” or the “Company”), a clinical-stage immuno-oncology company focused on the development of therapies and treatments targeting cancer treatment resistance, today announced that as part of its commitment to investor outreach, management will be participating in the following investor conferences in September 2021.
H.C. Wainwright 23rd Annual Global Investor Conference
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
2021Cantor Virtual Global Healthcare Conference
Format: Fireside Chat with analyst Alethia Young at 11:20a.m. ET and 1-on-1 meetings (click here for live webcast).
An archived replay of the Oppenheimer and Cantor webcasts will be available on the Investor section of the company’s website at https://ir.portagebiotech.com/news-and-events/events following the presentation.
About Portage Biotech Inc.
This news release contains statements about the Company’s information that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.
FOR MORE INFORMATION, PLEASE CONTACT:
Face the Music: The New Age of Bluetooth
Brunch Served in ITEXPO #TECHSUPERSHOW Expo Hall
WiFi6: Securing the Remote Future